New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has provided the ...

Researchers have long believed — and the authors of a new study hypothesized — that schizophrenics have lower brain levels of the neurotransmitter serotonin, and that those lower levels are associated ...

Schizophrenia affects around 23 million people globally, or one in 345 people. The illness can beset sufferers with ...

For decades, schizophrenia and bipolar disorder have been diagnosed from the outside in, through behavior, mood, and memory ...

Results also indicate how these genetics might affect a person’s biology to increase their risk of different mental ...

New research from the Institute of Psychiatry, Psychology & Neuroscience, supported by the Population Mental Health ...

The idea of becoming "normal" again is an illusion, as nothing truly defines what normal is, but you can achieve feeling no ...

Schizoaffective disorder and schizophrenia share some symptoms and treatments. The main difference is that schizoaffective disorder has a mood compenent, which can involve mania or depression. Some ...

People diagnosed with schizophrenia can often experience delusions and hallucinations, which cause them to see or hear things that are not there and believe things that are untrue. The disorder can ...

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies showed ...